A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea

Trial Profile

A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2017

At a glance

  • Drugs Azelaic acid (Primary) ; Brimonidine; Metronidazole
  • Indications Rosacea
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 19 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 11 Feb 2016 Planned number of patients changed from 800 to 200 as reported by ClinicalTrials.gov.
    • 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top